0001939796-23-000001.txt : 20230810 0001939796-23-000001.hdr.sgml : 20230810 20230810102229 ACCESSION NUMBER: 0001939796-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 EFFECTIVENESS DATE: 20230810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RevOpsis Therapeutics, Inc. CENTRAL INDEX KEY: 0001939796 IRS NUMBER: 883217217 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489317 FILM NUMBER: 231157713 BUSINESS ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 BUSINESS PHONE: 6462215178 MAIL ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 D 1 primary_doc.xml X0708 D LIVE 0001939796 RevOpsis Therapeutics, Inc. 4109 CHANDLERWOOD SPRINGFIELD IL ILLINOIS 62711 6462215178 DELAWARE RevOpsis Therapeutics LLC None Corporation true 2022 Ramanath Bhandari 4109 Chandlerwood Springfield IL ILLINOIS 62711 Executive Officer Director Ram Palanki 4109 Chandlerwood Springfield IL ILLINOIS 62711 Director Biotechnology Decline to Disclose 06c false 2023-07-26 false true false 25000 7895004 7895004 0 false 36 0 0 0 false RevOpsis Therapeutics, Inc. Ramanath Bhandari Ramanath Bhandari Chief Executive Officer 2023-08-09